An Integrated Care Platform Based on the Monitoring of Older Individual Intrinsic Capacity for Inclusive Health (CAREUP)
NCT ID: NCT05963399
Last Updated: 2024-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
90 participants
INTERVENTIONAL
2024-04-30
2024-12-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Life Monitoring for Rural Older Adults
NCT06974006
Elderly Chronic Diseases Online Biometric Analysis Home Living Technology
NCT02155686
Evaluation of a New System for Heart Rate and SpO2 Measurement.
NCT05240079
The Smartphone and Wearable Detected Atrial Arrhythmia in Older Adults Case Finding Study (Smart in OAC - AFNET 9)
NCT04579159
Wearable Monitoring Device in Daily Lives of Community-dwelling Older Adults
NCT05269303
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
older adults
Elderly adults who live independently in their own home in rural or urban areas.
CAREUP platform
The Experimental Group will test the CAREUP platform at home for 12 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CAREUP platform
The Experimental Group will test the CAREUP platform at home for 12 months.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* In good physical and cognitive status;
* Able to stand and walk unaided;
* Availability to sign the Informed Consent;
* Ability to use smartphones/tablets independently.
Exclusion Criteria
* Allergy to nickel components;
* Lack of written informed consent;
* Acute or untreated medical problems such as history of syncopal episodes, epilepsy and vertigo not controlled pharmacologically; serious dysfunction of the autonomic system; severe behavioural syndromes not compensated by drugs; concurrent neurological diseases; severe systemic diseases with life expectancy \< 1 year;
* A myocardial infarction or stroke within 6 months;
* Painful arthritis, spinal stenosis, amputation, painful foot lesions or neuropathy limiting balance and mobility;
* Uncontrolled hypertension;
* Pacemaker or implantable cardioverter defibrillator;
* Diagnosis of mild and or/advanced Parkinson's disease or other neuromuscular disorder;
* Diagnosis of mild and/or advance cognitive impairments
* Metastatic cancer or immunosuppressive therapy;
* Significant visual or hearing impairment
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
European Union
OTHER
Istituto Nazionale di Ricovero e Cura per Anziani
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vera Stara
Role: STUDY_CHAIR
IRCCS INRCA, Ancona, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
EURAG Austria
Vienna, , Austria
IRCCS INRCA Hospital
Ancona, , Italy
Ana Aslan International Foundation
Bucharest, , Romania
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Eva Reither
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INRCA_007_2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.